NCT02832206View on ClinicalTrials.gov

Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

hybrid ablation

Surgical thoracoscopic epicardial ablation (box-lesion) and left atrial appendage occlusion , followed (after 2-3months) by electrophysiological examination, and catheter ablation (completion of the box-lesion, cavotricuspid isthmus ablation and other ablation if indicated)

Trial Locations (1)

10000

Charles University, Third Faculty of Medicine, Prague

All Listed Sponsors
lead

Charles University, Czech Republic

OTHER

NCT02832206 - Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation | Biotech Hunter | Biotech Hunter